Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | -0.021 | 0.7 |
mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |